Biotechnology Cradle Secures $73m Series B to Accelerate AI-Driven Protein Engineering Cradle, the pioneering platform for AI-powered protein engineering in Amsterdam, Netherlands, has successfully raised US$73m in Series B funding. The round, led by IVP with participation from existing investors Index Ventures and Kindred Capital, brings the company’s total funding to over US$100m. Cradle’s generative AI platform is already used across multiple industries, including pharmaceuticals, agriculture, […] Written by Georg Kääb November 30, 2024November 30, 2024 Saving Bookmark this article Bookmarked
New patent for Vanda Pharms drug HETLIOZ Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are thirty patents protecting this drug and two Paragraph IV challenges. Drug patent litigation for HETLIOZ. This drug has one […] Written by DrugPatentWatch – Make Better Decisions December 20, 2024December 20, 2024 Saving Bookmark this article Bookmarked
A proteome-wide yeast degron collection for the dynamic study of protein function Genome-wide collections of yeast strains, known as libraries, revolutionized the way systematic studies are carried out. Specifically, libraries that involve a cellular perturbation, such as the deletion collection, have facilitated key biological discoveries. However, short-term rewiring and long-term accumulation of suppressor mutations often obscure the functional consequences of such perturbations. We present the AID library […] Written by Admin December 19, 2024December 19, 2024 Saving Bookmark this article Bookmarked
New patent for Vanda Pharms drug HETLIOZ Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are thirty patents protecting this drug and two Paragraph IV challenges. Drug patent litigation for HETLIOZ. This drug has one […] Written by DrugPatentWatch – Make Better Decisions December 20, 2024December 20, 2024 Saving Bookmark this article Bookmarked
A proteome-wide yeast degron collection for the dynamic study of protein function Genome-wide collections of yeast strains, known as libraries, revolutionized the way systematic studies are carried out. Specifically, libraries that involve a cellular perturbation, such as the deletion collection, have facilitated key biological discoveries. However, short-term rewiring and long-term accumulation of suppressor mutations often obscure the functional consequences of such perturbations. We present the AID library […] Written by Admin December 19, 2024December 19, 2024 Saving Bookmark this article Bookmarked
Columbia Climate School Hosts Ninth Annual Sustainability Careers Reception – State of the Planet Practitioners who attended the 2024 Sustainability Careers Reception. (*See below for names and affiliations) Last month, the Columbia Climate School hosted its ninth annual Sustainability Careers Reception at the Columbia Club in Midtown Manhattan. Thirty-three sustainability professionals and 88 Columbia students from varying backgrounds and degree pursuits gathered to discuss the ever-pressing challenges and real-world […] Written by Guest December 19, 2024December 19, 2024 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked